Jupiter Asset Management LTD Corcept Therapeutics Inc Transaction History

Jupiter Asset Management LTD

$11 Billion
Q3 2024

A detailed history of Jupiter Asset Management LTD transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Jupiter Asset Management LTD holds 256,270 shares of CORT stock, worth $15.2 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

256,270

Previous 540,696 52.6%

Holding current value

$15.2 Million

Previous $17.6 Million 32.52%

% of portfolio

0.11%

Previous 0.17%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$29.51 - $46.26 $8.39 Million - $13.2 Million	-284,426 Reduced 52.6%	256,270 $11.9 Million
Q2 2024 Aug 08, 2024	SELL	$22.21 - $34.48 $4.53 Million - $7.03 Million	-203,773 Reduced 27.37%	540,696 $17.6 Million
Q1 2024 May 10, 2024	BUY	$21.1 - $27.46 $14.5 Million - $18.8 Million	684,863 Added 1148.98%	744,469 $18.8 Million
Q4 2023 Feb 09, 2024	BUY	$24.82 - $32.88 $1.48 Million - $1.96 Million	59,606 New	59,606 $1.94 Million
Q2 2022 Aug 10, 2022	SELL	$17.33 - $25.3 $3.82 Million - $5.58 Million	-220,629 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$16.53 - $25.21 $295,837 - $451,183	-17,897 Reduced 7.5%	220,629 $4.97 Million
Q4 2021 Feb 11, 2022	SELL	$17.1 - $23.34 $58,362 - $79,659	-3,413 Reduced 1.41%	238,526 $4.65 Million
Q3 2021 Nov 10, 2021	BUY	$19.68 - $22.53 $2.39 Million - $2.74 Million	121,452 Added 100.8%	241,939 $4.76 Million
Q1 2021 May 12, 2021	SELL	$23.49 - $30.56 $4.08 Million - $5.31 Million	-173,644 Reduced 59.04%	120,487 $2.87 Million
Q4 2020 Feb 10, 2021	SELL	$16.78 - $27.3 $5.95 Million - $9.68 Million	-354,730 Reduced 54.67%	294,131 $7.69 Million
Q3 2020 Nov 10, 2020	BUY	$12.46 - $19.98 $8.08 Million - $13 Million	648,861 New	648,861 $11.3 Million

Others Institutions Holding CORT

# of Institutions

347

Shares Held

86.6M

Call Options Held

1.12M

Put Options Held

667K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.34B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jupiter Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Jupiter Asset Management LTD with notifications on news.

Account

Jupiter Asset Management LTD Corcept Therapeutics Inc Transaction History